Showing results (241-250 of 293) with videos related to

Sort By:
Pageof 30
Journal of Clinical Epidemiology|June 1, 1995
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) StudyE Barasch, M Benderly, E Graff, et al.
The American Journal of Cardiology|March 15, 1991
Effects of nisoldipine on myocardial ischemia during exercise and during daily activityD Tzivoni, S Banai, S Botvin, et al.
The Journal of Clinical Psychiatry|September 28, 2010
Is trauma a causal agent of psychopathologic symptoms in posttraumatic stress disorder? Findings from identical twins discordant for combat exposureMark W Gilbertson, Alexander C McFarlane, Frank W Weathers, et al.
The American Journal of Cardiology|April 15, 1993
Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)U Goldbourt, S Behar, H Reicher-Reiss, et al.
American Heart Journal|August 1, 1997
Long-term antianginal and antiischemic effects of mibefradil, the novel T-type calcium channel blocker: a multicenter, double-blind, placebo-controlled, randomized comparison with sustained-release diltiazemG J Davies, I Kobrin, A Caspi, et al.
Heliyon|July 18, 2022
Entourage effect for phenolic compounds on production and metabolism of mammary epithelial cellsY Shalev, O Hadaya, R Bransi-Nicola, et al.
The Journal of Clinical Psychiatry|July 14, 2017
Secondary Prevention of Chronic PTSD by Early and Short-Term Administration of Escitalopram: A Prospective Randomized, Placebo-Controlled, Double-Blind TrialJoseph Zohar, Leah Fostick, Alzabeta Juven-Wetzler, et al.
American Journal of Therapeutics|July 29, 1999
Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil InvestigatorsJ C Somberg, V Yelamanchi, J Molnar, et al.
British Journal of Clinical Pharmacology|December 22, 1999
Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiencyR Greenbaum, P Zucchelli, A Caspi, et al.
Psychological Medicine|December 2, 2015
Which adolescents develop persistent substance dependence in adulthood? Using population-representative longitudinal data to inform universal risk assessmentM H Meier, W Hall, A Caspi, et al.
Pageof 30